Twin Lakes Capital Management’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.1K | Hold |
2,195
| – | – | 0.01% | 188 |
|
|
2025
Q1 | $14.2K | Hold |
2,195
| – | – | 0.01% | 176 |
|
|
2024
Q4 | $16.1K | Hold |
2,195
| – | – | 0.01% | 183 |
|
|
2024
Q3 | $16.4K | Hold |
2,195
| – | – | 0.01% | 187 |
|
|
2024
Q2 | $19.5K | Hold |
2,195
| – | – | 0.01% | 176 |
|
|
2024
Q1 | $22.2K | Hold |
2,195
| – | – | 0.02% | 173 |
|
|
2023
Q4 | $22.1K | Hold |
2,195
| – | – | 0.02% | 169 |
|
|
2023
Q3 | $20.6K | Hold |
2,195
| – | – | 0.02% | 174 |
|
|
2023
Q2 | $53.8K | Hold |
2,195
| – | – | 0.04% | 134 |
|
|
2023
Q1 | $51.1K | Hold |
2,195
| – | – | 0.04% | 133 |
|
|
2022
Q4 | $55.6K | Hold |
2,195
| – | – | 0.04% | 131 |
|
|
2022
Q3 | $42K | Buy |
+2,195
| New | +$42K | 0.03% | 147 |
|
|
2022
Q2 | – | Sell |
-2,195
| Closed | -$56K | – | 281 |
|
|
2022
Q1 | $56K | Hold |
2,195
| – | – | 0.03% | 151 |
|
|
2021
Q4 | $92K | Hold |
2,195
| – | – | 0.05% | 124 |
|
|
2021
Q3 | $96K | Hold |
2,195
| – | – | 0.06% | 114 |
|
|
2021
Q2 | $104K | Buy |
+2,195
| New | +$104K | 0.06% | 98 |
|